NDC 50090-3422-01 - Ezetimibe
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-3422
- Requested NDC
- 50090-3422-01
- Package NDCs from labels
- 50090-3422-0, 50090-3422-1, 50090-3422-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-09-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ezetimibe - A-S Medication Solutions | A-S Medication Solutions | 2024-09-29 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-3422-0 | Ezetimibe | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 50090-3422-1 | Ezetimibe | 90 in 1 BOTTLE | TABLET | 90 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-3422 | EZETIMIBE TABLET [A-S MEDICATION SOLUTIONS] | 9 | Current NDC, Legacy NDC, 2 package rows | 20241003_63ecbbf1-a6de-493f-9710-812ff45cb4d3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-3422-0 | EA - Each | 50090-3422 | 5b69c374-bd17-4b9b-8a49-a7a0b7635a44 | 1 | 2019-05-02 |
| 50090-3422-1 | EA - Each | 50090-3422 | 413c97f7-ed5b-483b-8183-131d398cf92b | 1 | 2019-05-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ezetimibe | EZETIMIBE | Ascend Laboratories, LLC | 206d702c-b09a-4555-972b-6555d6d6d6e6 | 2025-06-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | 3a80b668-51cd-42be-8497-8712b0508422 | 2025-05-12 | Warnings, Adverse reactions | ANDA209838 349556 EOR26LQQ24 |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Ascend Laboratories, LLC | c90e8c96-e130-42d7-bf0d-5833652e40d5 | 2025-05-02 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Aurobindo Pharma Limited | 726b1e63-437a-4b3b-b773-3ac47a5c0f38 | 2025-03-13 | Warnings, Adverse reactions | ANDA209838 59651-052 349556 60081062-9f4b-4cf5-9c24-02b5a0b7f792 726b1e63-437a-4b3b-b773-3ac47a5c0f38 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | NorthStar Rx LLC | 5f5644a9-e019-4e5d-ab6f-3d30b1024c5a | 2025-03-13 | Warnings, Adverse reactions | ANDA209838 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Proficient Rx LP | 55b18d8f-40e0-48ba-baf1-79a0d1bb2ee2 | 2025-03-01 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Ezetimibe | EZETIMIBE | Amneal Pharmaceuticals NY LLC | 3fadf4e9-017d-4ccd-91dc-a89b981eb138 | 2025-02-10 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 368GB5141J |
| ezetimibe | EZETIMIBE | Zydus Lifesciences Limited | de814dcd-4759-4e9c-a650-335fb885a79d | 2024-11-28 | 349556 EOR26LQQ24 | |
| Ezetimibe and Simvastatin | EZETIMIBE AND SIMVASTATIN | Aurobindo Pharma Limited | 79dadfde-35c7-4937-9c82-1728fb6be2fb | 2024-10-22 | Warnings, Adverse reactions | EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 5877150f-2807-435e-8e5b-a07dc7dbfd27 | 2024-10-21 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 1afdb764-c5da-4982-beae-9be61bdcbcdc | 2024-10-21 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 63ecbbf1-a6de-493f-9710-812ff45cb4d3 | 2024-09-29 | Warnings, Adverse reactions | ANDA209838 50090-3422-0 50090-3422-1 50090-3422 50090342201 349556 a1915b61-123e-406c-ba03-a6ad459829d1 63ecbbf1-a6de-493f-9710-812ff45cb4d3 EOR26LQQ24 |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 368GB5141J |
| Ezetimibe | EZETIMIBE | Glenmark Pharmaceuticals Inc., USA | ac539a72-77e4-419c-b1d9-42002e9cecf7 | 2024-07-31 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| EZETIMIBE | EZETIMIBE | Camber Pharmaceuticals, Inc. | c07fe2e0-dad4-48b5-8a07-7d57a4035ccd | 2024-07-19 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Bryant Ranch Prepack | d6b4fd12-9954-42ba-b42a-56f3747c47ff | 2024-07-09 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | ScieGen Pharmaceuticals Inc | 11de499b-ad8a-46a6-9021-c8eba72ae414 | 2024-06-12 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | Macleods Pharmaceuticals Limited | ebe3fa4e-82c4-4a9a-9aec-f64019391f4e | 2024-05-13 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.